CLINICAL_TRIALS
trial_result
· 2022-03-08
Clinical Trial Update: Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein [Phase 4]
Summary
Phase 4 trial evaluating whether splitting mealtime insulin doses after high-fat/protein mixed meals improves outcomes in type 1 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sohag University | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED